These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25551306)

  • 21. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metallo-beta-lactamase-mediated resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates].
    Mereuţă AI; Tuchiluş C; Bădescu AC; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1208-13. PubMed ID: 22276471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Courtois N; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.
    Kidd TJ; Ramsay KA; Hu H; Marks GB; Wainwright CE; Bye PT; Elkins MR; Robinson PJ; Rose BR; Wilson JW; Grimwood K; Bell SC;
    Eur Respir J; 2013 May; 41(5):1091-100. PubMed ID: 22878877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.
    Anuj SN; Whiley DM; Kidd TJ; Ramsay KA; Bell SC; Syrmis MW; Grimwood K; Wainwright CE; Nissen MD; Sloots TP
    Clin Microbiol Infect; 2011 Sep; 17(9):1403-8. PubMed ID: 21129101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis.
    Tai AS; Sidjabat HE; Kidd TJ; Whiley DM; Paterson DL; Bell SC
    J Microbiol Methods; 2015 Apr; 111():105-7. PubMed ID: 25680305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.
    Salunkhe P; Smart CH; Morgan JA; Panagea S; Walshaw MJ; Hart CA; Geffers R; Tümmler B; Winstanley C
    J Bacteriol; 2005 Jul; 187(14):4908-20. PubMed ID: 15995206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
    Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of isolates of carbapenemase-producing Pseudomonas aeruginosa from seven Colombian provinces].
    Saavedra SY; Duarte C; González MN; Realpe ME
    Biomedica; 2014 Apr; 34 Suppl 1():217-23. PubMed ID: 24968053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing β-lactamases in Pseudomonas aeruginosa in Turkey.
    Iraz M; Duzgun AO; Cicek AC; Bonnin RA; Ceylan A; Saral A; Nordmann P; Sandalli C
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):292-4. PubMed ID: 24428980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients.
    Douraghi M; Ghasemi F; Dallal MM; Rahbar M; Rahimiforoushani A
    J Prev Med Hyg; 2014 Jun; 55(2):50-3. PubMed ID: 25916020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of plasmid OXA and other β-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the Clinical University Hospital in northeastern Poland.
    Sacha P; Michalska A; Ojdana D; Wieczorek P; Hauschild T; Majewski P; Tryniszewska E
    New Microbiol; 2015 Apr; 38(2):271-5. PubMed ID: 25938753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.